国际流行病学传染病学杂志
國際流行病學傳染病學雜誌
국제류행병학전염병학잡지
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY AND INFECTIOUS DISEASE
2009年
5期
296-298
,共3页
孙仁华%姜晓晖%陈敏华%吕治林
孫仁華%薑曉暉%陳敏華%呂治林
손인화%강효휘%진민화%려치림
肺炎%呼吸机相关性%感染%中药
肺炎%呼吸機相關性%感染%中藥
폐염%호흡궤상관성%감염%중약
Pneumonia%ventilator-associated%Infection%Chinese medicine
目的 探讨清肺组方对呼吸机相关性肺炎(VAP)的治疗作用.方法 对107例VAP患者在西医常规处理的同时,采用随机双盲法分为治疗组和对照组,分别给予清肺组方(治疗组)和安慰剂(对照组)治疗,比较两组患者在VAP临床症状、胸片改善情况、病死率和病程方面的差异,客观评价中医药对VAP的治疗价值.结果 治疗组临床症状改善情况优于对照组(X2=3.97,P＜0.01),胸片改善情况亦优于对照组(X2=4.05,P＜0.01),治疗组VAP病死率(X2=4.86,P＜0.05)下降,VAP病程缩短(t=2.79,P＜0.01).结论 清肺组方对VAP有治疗作用.
目的 探討清肺組方對呼吸機相關性肺炎(VAP)的治療作用.方法 對107例VAP患者在西醫常規處理的同時,採用隨機雙盲法分為治療組和對照組,分彆給予清肺組方(治療組)和安慰劑(對照組)治療,比較兩組患者在VAP臨床癥狀、胸片改善情況、病死率和病程方麵的差異,客觀評價中醫藥對VAP的治療價值.結果 治療組臨床癥狀改善情況優于對照組(X2=3.97,P＜0.01),胸片改善情況亦優于對照組(X2=4.05,P＜0.01),治療組VAP病死率(X2=4.86,P＜0.05)下降,VAP病程縮短(t=2.79,P＜0.01).結論 清肺組方對VAP有治療作用.
목적 탐토청폐조방대호흡궤상관성폐염(VAP)적치료작용.방법 대107례VAP환자재서의상규처리적동시,채용수궤쌍맹법분위치료조화대조조,분별급여청폐조방(치료조)화안위제(대조조)치료,비교량조환자재VAP림상증상、흉편개선정황、병사솔화병정방면적차이,객관평개중의약대VAP적치료개치.결과 치료조림상증상개선정황우우대조조(X2=3.97,P＜0.01),흉편개선정황역우우대조조(X2=4.05,P＜0.01),치료조VAP병사솔(X2=4.86,P＜0.05)하강,VAP병정축단(t=2.79,P＜0.01).결론 청폐조방대VAP유치료작용.
Objective To study the clinical effect of qingfeizufang therapy on ventilator-associated pneumonia(VAP).Methods 107 patients with VAP were randomly divided into the treatment group and the control group.The treatment group accepted the extra Qingfeizufang treatment base on the common treatment,the clinical manifestation,the duration of VAP,the mortality rate between two groups were compared.Results Comparing with the control group,the treatment group obtained the better results in sputum drainage(X2 = 3.97,P＜0.01),in anti-inflammatory and bacteriostasis,and also in shortening the duration of VAP(t = 2.79,P＜0.01),in decreasing the mortality rate(X2 = 4.86,P＜0.05).Conclusions Qingfeizufang is effective on the treatment of VAP.
